The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies
- PMID: 32614649
- PMCID: PMC7553688
- DOI: 10.1080/21645515.2020.1765622
The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies
Abstract
HIV-1 sexual transmission occurs mostly through contaminated semen, which is a complex mixture of soluble factors with immunoregulatory functions and cells. It is well established that semen cells from HIV-1-infected men are able to produce the virus and that are harnessed to efficiently interact with mucosal barriers exposed during sexual intercourse. Several cofactors contribute to semen infectivity and may enhance the risk of HIV-1 transmission to a partner by increasing local HIV-1 replication in the male genital tract, thereby increasing the number of HIV-1-infected cells and the local HIV-1 shedding in semen. The introduction of combination antiretroviral therapy has improved the life expectancy of HIV-1 infected individuals; however, there is evidence that systemic viral suppression does not always reflect full viral suppression in the seminal compartment. This review focus on the role semen leukocytes play in HIV-1 transmission and discusses implications of the increased resistance of cell-mediated transmission to immune-based prevention strategies.
Keywords: HIV-1; male genital tract; mucosal immunity; mucosal transmission; semen.
Similar articles
-
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.J Antimicrob Chemother. 2016 Nov;71(11):3202-3205. doi: 10.1093/jac/dkw271. Epub 2016 Jul 17. J Antimicrob Chemother. 2016. PMID: 27432601
-
Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.J Infect Dis. 2013 Apr 15;207(8):1226-34. doi: 10.1093/infdis/jit026. Epub 2013 Jan 17. J Infect Dis. 2013. PMID: 23329849
-
Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.J Virol. 2015 Jun;89(11):5772-87. doi: 10.1128/JVI.03628-14. Epub 2015 Apr 1. J Virol. 2015. PMID: 25833047 Free PMC article.
-
Origins of HIV-infected leukocytes and virions in semen.J Infect Dis. 2014 Dec 15;210 Suppl 3:S622-30. doi: 10.1093/infdis/jiu328. J Infect Dis. 2014. PMID: 25414416 Review.
-
Antiretroviral therapy to reduce the sexual transmission of HIV.J HIV Ther. 2003 Aug;8(3):55-66. J HIV Ther. 2003. PMID: 12951543 Review.
Cited by
-
Update on known and emergent viruses affecting human male genital tract and fertility.Basic Clin Androl. 2024 Mar 14;34(1):6. doi: 10.1186/s12610-024-00222-5. Basic Clin Androl. 2024. PMID: 38486154 Free PMC article. Review.
-
Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity.Sci Rep. 2024 Sep 9;14(1):21050. doi: 10.1038/s41598-024-71499-9. Sci Rep. 2024. PMID: 39251689 Free PMC article.
-
HIV-Host Cell Interactions.Cells. 2023 May 9;12(10):1351. doi: 10.3390/cells12101351. Cells. 2023. PMID: 37408185 Free PMC article. Review.
-
Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier.J Virol. 2022 Apr 13;96(7):e0020222. doi: 10.1128/jvi.00202-22. Epub 2022 Mar 17. J Virol. 2022. PMID: 35297667 Free PMC article.
-
Round Cells in Diagnostic Semen Analysis: A Guide for Laboratories and Clinicians.Br J Biomed Sci. 2022 Feb 2;79:10129. doi: 10.3389/bjbs.2021.10129. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996519 Free PMC article. Review.
References
-
- Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts [Internet]. Clin Infect Dis. 2007;44(7):981–87. [accessed 2020 March4]. http://www.ncbi.nlm.nih.gov/pubmed/17342654. - PubMed
-
- Rametse CL, Olivier AJ, Masson L, Barnabas S, McKinnon LR, Ngcapu S, Liebenberg LJ, Jaumdally SZ, Gray CM, Jaspan HB, et al. Role of semen in altering the balance between inflammation and tolerance in the female genital tract: does it contribute to HIV risk? Viral Immunol. 2014;27(5):200–06. doi:10.1089/vim.2013.0136. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical